| Patents for B82Y 5 - Nano-biotechnology or nano-medicine, e.g. protein engineering or drug delivery (2,162) |
|---|
| 04/07/2010 | EP2170332A1 A medicament for treating glaucoma comprising as an active ingredient cyclodextrin-clathrate compound of cilostazol |
| 03/31/2010 | EP2168981A2 A Fibrin/Fibrinogen-binding conjugate |
| 03/31/2010 | EP2167031A2 Hyperbranched polymers based on cyclodextrins and poly(amidoamines) for the controlled release of insoluble drugs |
| 02/24/2010 | EP2155770A1 A versatile nucleic acid hairpin motif for programming biomolecular self-assembly pathways |
| 02/24/2010 | EP2155255A2 Compositions that include a hydrophobic compound and a polyamino acid conjugate |
| 02/17/2010 | EP2153812A1 X-ray opaque infiltrant |
| 02/17/2010 | EP2152319A1 Near-infrared dyes as surface enhanced raman scattering reporters |
| 02/03/2010 | EP2148675A1 Anti-cancer medicine both for diagnosing and treating cancer |
| 12/30/2009 | EP2137208A2 Compounds for diagnosing apoptosis |
| 12/23/2009 | EP2134642A1 In vivo tumor targeting and spectroscopic detection with surface-enhanced raman nanoparticle tags |
| 12/16/2009 | EP2131871A2 Use of metal nanoparticles for diagnosing alzheimer disease |
| 12/02/2009 | EP2128203A1 Die-form metal effect pigments containing copper, method for their manufacture and use |
| 12/02/2009 | EP2125220A1 Transfection microarrays |
| 11/25/2009 | EP2122352A2 A method and a microdevice for the identification and/or quantification of an analyte in a biological sample |
| 11/25/2009 | EP2121139A1 Formulations for cancer treatment |
| 04/30/2009 | WO2009054512A1 β-CHITIN NANOFIBER, PROCESS FOR THE PRODUCTION OF THE SAME, β-CHITIN NANOFIBER DISPERSION, NANOFIBRIL STRUCTURE AND CHITIN COMPOSITE |
| 03/25/2009 | EP2038900A2 A method for manipulating magnetic particles in a liquid medium |
| 03/25/2009 | EP2038051A2 A device and method for manipulating and mixing magnetic particles in a liquid medium |
| 03/11/2009 | EP2033934A1 Hollow-fiber-like organic nanotube and process for production thereof |
| 02/11/2009 | EP2022753A1 Flexible micro/nanofluidic devices |
| 01/14/2009 | EP2012937A2 Systems and methods for producing multilayered particles, fibers and sprays and methods for administering the same |
| 01/08/2009 | WO2009005178A1 Microarrays for detection and identification of microorganisms associated with periodontal diseases and method for diagnosis of infectious oral diseases using the microarray |
| 10/29/2008 | EP1984929A1 Preparation of poly(ethylene oxide)-coated nanoparticles of maghemite |
| 08/27/2008 | EP1959994A2 Botulinum nanoemulsions |
| 07/30/2008 | EP1950227A1 HYDROXYPROPYL-SULFOBUTYL-ß-CYCLODEXTRIN, THE PREPARATION METHOD,THE ANALYTICAL METHOD AND THE PHARMACUTICAL APPLICATION THEREOF |
| 07/30/2008 | EP1948681A2 Pyroglue |
| 07/23/2008 | EP1945159A2 Magnetic nanoscale particle compositions, and therapeutic methods related thereto |
| 07/09/2008 | EP1940513A1 A nanoparticle suitable for delivery of a biomolecule into or out of a membrane enclosed cell or cell organelle |
| 05/28/2008 | EP1925696A2 Iron-gold barcode nanowire and manufacturing method thereof |
| 02/20/2008 | EP1888510A2 Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications |
| 12/19/2007 | EP1865839A2 Functionalized magnetic nanoparticles and methods of use thereof |
| 10/10/2007 | EP1842524A1 Cleaning liquid for oral cavity |
| 10/10/2007 | EP1841468A2 Laser activated nanothermolysis of cells |
| 09/05/2007 | EP1827428A1 Compositions comprising an epothilone and production methods |
| 06/27/2007 | EP1799268A2 Magnetic particles for therapy and diagnosis |
| 05/16/2007 | EP1784163A1 Nano-emulsion, the use thereof, and preparation method thereof |
| 05/02/2007 | EP1778651A2 Multivalent chelators for modifying and organizing of target molecules |
| 04/18/2007 | EP1773407A2 Nanoparticles with inorganic core and methods of using them |
| 03/07/2007 | EP1759012A2 Recombinase polymerase amplification |
| 02/22/2007 | US20070042485 Modified TRAP protein for producing nano-scale electrical devices, and a method for producing such a protein |
| 12/07/2006 | US20060275187 Ultraviolet-response thin film photocatalyst and application thereof |
| 11/22/2006 | EP1723431A1 Hybrid nanoparticles including an ln2o3 core and having bioligands, and method for preparing same |
| 10/18/2006 | EP1711211A1 Ultrasound contrast agents for molecular imaging |
| 10/18/2006 | EP1711203A1 Targeted atherosclerosis treatment |
| 10/04/2006 | CN1842371A Ultraviolet-responsive thin film photocatalyst and application thereof |
| 09/06/2006 | EP1696784A2 Bioconjugated nanostructures, methods of fabrication thereof, and methods of use thereof |
| 01/04/2006 | EP1611953A1 Ultraviolet-responsive thin film photocatalyst and application thereof |
| 01/04/2006 | EP1610752A2 Localized drug delivery using drug-loaded nanocapsules and implantable device coated with the same |
| 08/24/2005 | EP1565566A2 Protein synthesis monitoring (psm) |
| 05/18/2005 | EP1530482A1 Use of urease for inhibiting cancer cell growth |
| 12/29/2004 | EP1491210A1 Therapeutic drug using antibody-presenting hollow protein nanoparticles and hollow protein nanoparticles |
| 11/17/2004 | EP1476473A1 Novel natural cyclodextrin complexes |
| 10/21/2004 | WO2004089815A1 Member for molecular elaboration |
| 10/21/2004 | WO2004089544A1 Ultraviolet-responsive thin film photocatalyst and application thereof |
| 10/21/2004 | CA2521168A1 Ultraviolet-responsive thin film photocatalyst and application thereof |
| 09/01/2004 | EP1450842A2 Process of preparation of formulations of the peptide angiotensin-(1-7) and its analogues, agonistic and antagonists using cyclodextrins, lipossomes and biodegradable polymers and/or mixtures and products thereof |
| 05/26/2004 | EP1421954A1 Materials sustainedly releasing drug in vivo |
| 01/02/2004 | EP1373368A1 Compounds for a controlled release of active compounds |
| 10/22/2003 | EP1353699A1 Cyclodextrin-drospirenone inclusion complexes |
| 08/14/2002 | EP1230907A1 Metal oxide/silica composite and cosmetic comprising the same |
| 10/24/2001 | EP1147416A2 Assays involving colloids and non-colloidal structures |
| 01/03/2001 | EP1064026A1 Enhancement of intracellular delivery and tissue targeting of drugs and genes |